Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shree PacetronixBOM:527005 +7.52%76 EV-to-EBIT is 13.09 as of Sep. 22, 2026, which is 4% above its 10-year median of 12.59. GuruFocus rates BOM:527005 with a GF Score™ of 76/100 and a GF Value™ of ₹152.11 (Fairly Valued). The stock has 1 warning sign investors should review. Among 482 Medical Devices & Instruments companies, Shree Pacetronix ranks better than 63.49% on this metric.
The historical rank and industry rank for Shree Pacetronix's EV-to-EBIT or its related term are showing as below:
BOM:527005'
s EV-to-EBIT Range Over the Past 10 Years
Min: 3.72 Med: 12.59 Max: 395.15
Current: 13.08
During the past 13 years, the highest EV-to-EBIT of Shree Pacetronix was 395.15. The lowest was 3.72. And the median was 12.59.
BOM:527005's EV-to-EBIT is ranked better than 63.49% of 482
companies
in the Medical Devices & Instruments industry
Industry Median: 17.95
vs BOM:527005: 13.08
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Shree Pacetronix's Enterprise Value for the quarter that ended in Jun. 2026 was ₹ Mil.
Shree Pacetronix's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹46.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shree Pacetronix EV-to-EBIT Related Terms
Shree Pacetronix EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Shree Pacetronix's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:527005 vs ISRG, BDX, RMD: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, Shree Pacetronix's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shree Pacetronix EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shree Pacetronix's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Shree Pacetronix's EV-to-EBIT falls into.
Shree Pacetronix's current Enterprise Value is ₹609.1 Mil.
Shree Pacetronix's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹46.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shree Pacetronix (BOM:527005) has a EV-to-EBIT of 13.09 as of Sep. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Shree Pacetronix and its competitors. This is near median its historical median of 12.59. Over the past decade, Shree Pacetronix's EV-to-EBIT has ranged from 3.72 to 395.15. According to the industry distribution chart, Shree Pacetronix ranks #176 out of 482 companies in the Medical Devices & Instruments industry, placing it in the top 36.5%.
Is Shree Pacetronix's EV-to-EBIT too high?
Shree Pacetronix's current EV-to-EBIT of 13.09 is near median its 10-year median of 12.59. Over the past 10 years, this metric has ranged from a low of 3.72 to a high of 395.15. The Medical Devices & Instruments industry median EV-to-EBIT is 17.95. Shree Pacetronix's value of 13.09 is 27.1% below this industry median. Based on the distribution chart, Shree Pacetronix ranks #176 out of 482 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shree Pacetronix has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shree Pacetronix's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shree Pacetronix ranks #176 out of 482 companies for EV-to-EBIT. This puts Shree Pacetronix in the upper half of its industry. The industry median EV-to-EBIT is 17.95. Shree Pacetronix's value of 13.09 is 27.1% below this benchmark. Historically, Shree Pacetronix's own EV-to-EBIT has ranged from 3.72 to 395.15 over the past decade. While the company's 10-year median is 12.59 vs. the industry median of 17.95, Shree Pacetronix has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 17.95, based on 482 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shree Pacetronix's current EV-to-EBIT of 13.09 is 27.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Shree Pacetronix and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 17.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shree Pacetronix's current EV-to-EBIT is 13.09, which is near median its own 10-year median of 12.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Pacetronix stock overvalued right now?
Based on GuruFocus' analysis, Shree Pacetronix (BOM:527005) is currently considered Fairly Valued. The stock's GF Value™ is ₹152.11, compared to a current price of ₹191.25 — trading 25.7% above its estimated fair value. The current EV-to-EBIT is 13.09, which is near median its 10-year median of 12.59 and 27.1% below the Medical Devices & Instruments industry median of 17.95. Shree Pacetronix's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Shree Pacetronix (BOM:527005), the current EV-to-EBIT is 13.09 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shree Pacetronix (BOM:527005) Overvalued in 2026?
Based on GuruFocus' analysis, Shree Pacetronix stock appears to be overvalued.
The current stock price of ₹191.25 is trading 25.7% above its estimated GF Value™ of ₹152.11.
GuruFocus considers Shree Pacetronix to be Fairly Valued.
Key valuation signals for BOM:527005:
EV-to-EBIT: 13.09 (near median its 10-year median of 12.59)
GF Value™: ₹152.11 vs. price of ₹191.25 (25.7% above fair value)
Industry Position: 27.1% below the Medical Devices & Instruments median (#176 of 482)
No single metric tells the full story. See the BOM:527005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shree Pacetronix Ltd is engaged in the manufacturing of medical and surgical equipment and orthopedic appliances. It is in the business of manufacturing and selling Implantable Cardiac Pacemakers. Pacemakers are anti-bradycardia implantable devices intended for permanent ventricular or atrial pacing applications. The Company is engaged in only one segment i.e. Life Saving Devices. It sells its life-saving devices in India and internationally, of which the majority of revenue is generated from the sales made in India.
76GF Score
Get the complete analysis for BOM:527005
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:527005 has been successfully added to your 
